The rise of online medicine sales has created new opportunities for access-but also unprecedented risks from substandard and falsified (SF) products. This moderated session will examine the growing challenge of unsafe online pharmacies and explore evidence-based strategies to protect consumers. Panelists will discuss the roles of healthcare providers, regulators, and industry partners in strengthening public awareness, digital verification systems, and technology-enabled traceability tools. The discussion will highlight innovative approaches, policy responses, and cross-sector collaboration needed to safeguard patients in the expanding digital health marketplace.
The rise of online medicine sales has created new opportunities for access-but also unprecedented risks from substandard and falsified (SF) products. This moderated session will examine the growing challenge of unsafe online pharmacies and explore evidence-based strategies to protect consumers. Panelists will discuss the roles of healthcare providers, regulators, and industry partners in strengthening public awareness, digital verification systems, and technology-enabled traceability tools. The discussion will highlight innovative approaches, policy responses, and cross-sector collaboration needed to safeguard patients in the expanding digital health marketplace.
BESAFE2025 besafe@jh.eduTechnical Issues?
If you're experiencing playback problems, try adjusting the quality or refreshing the page.
Questions for Speakers?
Use the Q&A tab to submit questions that may be addressed in follow-up sessions.
